Abstract
Vibrio parahaemolyticus is a gram-negative facultative anaerobic bacterium implicated as the causative agent of several shrimp diseases. As part of the effort to provide biocontrol and cost-effective treatments, this research was designed to elucidate the effect of Morinda citrifolia fruit extract on the immunity of Penaeus vannamei postlarvae (PL) to V. parahaemolyticus. The methanol extract of M. citrifolia was vacuum evaporated, and the bioactive compounds were detected using gas chromatography‒mass spectrometry (GC‒MS). Thereafter, P. vannamei PL diets were supplemented with M. citrifolia at different concentrations (0, 10, 20, 30, 40, and 50 mg/g) and administered for 30 days before 24 h of exposure to the bacterium V. parahaemolyticus. A total of 45 bioactive compounds were detected in the methanol extract of M. citrifolia, with cyclononasiloxane and octadecamethyl being the most abundant. The survival of P. vannamei PLs fed the extract supplement was better than that of the control group (7.1–26.7% survival greater than that of the control group) following V. parahaemolyticus infection. Shrimp fed 50 mg/g M. citrifolia had the highest recorded survival. The activities of digestive and antioxidant enzymes as well as hepatopancreatic cells were significantly reduced, except for those of lipase and hepatopancreatic E-cells, which increased following challenge with V. parahaemolyticus. Histological assessment of the hepatopancreas cells revealed reduced cell degeneration following the administration of the plant extracts (expecially those fed 50 mg/g M. citrifolia) compared to that in the control group. Therefore, the enhanced immunity against V. parahaemolyticus infection in P. vannamei could be associated with the improved hepatopancreas health associated with M. citrifolia fruit extract supplementation.
Keywords: Hepatopancreas, Histopathology, Noni, Plant extract, Shrimp, Vibriosis
Subject terms: Biotechnology, Environmental sciences, Limnology, Endocrinology
Introduction
Shrimps have been recognized as the most common seafood products in the world1,2. Among the shrimp species traded, Penaeus vannamei, often referred to as whiteleg shrimp, is popular in many parts of the world3,4. The global popularity of whiteleg shrimp compared to that of other shrimp species is predicated on its fast-growing potential and tolerance to extreme environmental conditions5. Additionally, penaeid shrimp are far superior to other shrimp species in yield and fillet quality because they are rich in fatty acids and proteins6,7. These advantages may spur the expansion of P. vannamei culture, making P. vannamei one of the most important fisheries resources and economic activities worldwide8,9. However, the growth of these industries is threatened by the spread of disease.
This is because of the intensive culture of shrimp, which provides favorable conditions for disease infection. Consequently, these infections have elevated mortalities, amounting to billions of dollars in financial losses8,10. One such disease of concern for most shrimp farmers worldwide is acute hepatopancreatic necrosis disease (AHPND)11–13. It is caused by PirABVP-producing strain of Vibrio parahaemolyticus (VPAHPND) and was first observed in China14–16. However, losses due to AHPND disease have been reported in Southeast Asia, Mexico, and South America17. It is known to affect P. vannamei postlarvae within the first few days of stocking and often results in total mortality of the infected stocks17,18.
Several methods have been developed to control the spread of diseases in shrimp. Although vaccination and antibiotics are effective strategies18–22, the emergence of drug-resistant pathogens and the health risks associated with chemical treatments have led to the search for alternative methods8–26. Disease prevention through biocontrol measures has gained relevance in recent years. Research on the potential of plant parts and their extracts as important alternatives to antibiotics and chemical treatments is gaining attention27,28. This is due to their possession of natural resources, which have immunostimulant effects and hence can improve the immunity of the organism in which they are administered29–31. This treatment option is also considered for its cost-effectiveness and ability to protect the environment from chemical toxicity32.
The noni (Morinda citrifolia) is a polynesian plant found in many parts of the world and is traditionally used for the treatment of several human illnesses, such as arthritis, heart disease, diabetes, hypertension, fever, indigestions, and headaches33–36. Several studies have demonstrated the antimicrobial activity of Noni plants and their ability to improve the immune responses of aquaculture species37–39. Specifically, Rodriguez et al.40 reported that aqueous extracts of M. citrifolia improved the health of P. vannamei against pathogenic Vibrio spp. due to their antioxidant, immunomodulatory, and antimicrobial properties. Similarly, Chang et al.41 performed an in vitro test and showed that traditional water decocting extraction of M. citrifolia fruit had a bacteriostatic effect on V. parahaemolyticus isolated from P. vannamei. The improved immunity of aquatic species resulting from feed supplementation is often associated with improved activities in the digestive system32,42–45 and antioxidant responses46,47. In our earlier study, increasing concentrations of the methanolic fruit extract of M. citrifolia were administered to P. vannamei and found to improve the growth and physiological responses of the shrimps48. This study, therefore, was designed to elucidate the effect of the extract on the immunity of shrimp against V. parahaemolyticus infection. Hence, the survival, digestive enzyme activities, antioxidant responses, and histopathology of the hepatopancreas (tissue structure and hepatopancreatic cell number) were assessed before and after infection in this study.
Methodology
Preparation of the Morinda citrifolia fruit crude extract
Approximately five kilograms of M. citrifolia fruits obtained from the environs of Kuala Terengganu were rinsed with distilled water and subjected to extraction. In a preliminary study done (Not reported), methanol extraction of the M. citrifolia proved to yield more that alternative solvents such as aqueous and ethanol, hence was selected for this study. Methanol extraction of the fruits collected was performed according to the procedure described in the study by Natheer et al.49 with some modifications. In brief, the fruits were sliced into pieces (1 mm length × 1 mm width × 5 mm thickness) and dried in an oven (50 °C) for approximately five hours. Oven-dried samples were placed in a dry food processor and ground into powder form, followed by extraction with 70% methanol (at a ratio of 1:5, i.e., sample to methanol) for 48 h with constant stirring. The mixture obtained was then filtered through Whatman No. 1 filter paper with a diameter of 45 mm, a thickness of 180 µm, and a pore size of 11 µm. The filtrate was dried using rotary evaporation (Buchi R-215 Rotavapor System) under reduced pressure to expel the methanol. The extracts were prepared in three batches since each batch of extract prepared was sufficient for only 10 days of the feeding trial. To ensure that the extraction content was consistent in each of the batches used, the M. citrifolia fruits were collected from the same source, and the weight of the fruit before extraction and the percentage of water loss after drying were similar for the three batches of extraction. Additionally, the same ratio of 1:5 of the ground sample to be extracted in methanol (70%) was maintained for each batch of extractions. The final weight of the extract after the elimination of methanol was also approximately the same for all three extraction batches. Similarly, the extract and the prepared diet were kept in a chiller at 4 °C to ensure freshness and reduce degradation of the phytochemicals in the extracts during the ten days of use. It should be noted that all methods used in this study involving plants and the care or use of animals followed institutional, national, and international guidelines and legislation. Additionally, all necessary permissions and licenses needed for the collection and processing of the M. citrifolia fruits were obtained.
Bioactive compound analysis with gas chromatography‒mass spectrometry (GC‒MS)
The crude extract of M. citrifolia fruit was subjected to GC‒MS analysis [Agilent 6890 Series GC System with 5973 Network Mass Selective Detector equipped with SGE BPX5 column (30 m in length × 250 µm in diameter × 0.25 µm in thickness)] in triplicates. Helium gas was used as the carrier gas, and the split mode was selected. The details on the back inlet were as follows:
| Mode | Split |
|---|---|
| Initial Temperature | 280 °C |
| Pressure | 12.04 psi |
| Split ratio | 20:1 |
| Split flow | 20.0 ml/min |
The extract sample was diluted to a 10 × dilution in methanol and injected at a flow rate of 1.0 ml/min. The injection volume was 0.2 µl. The temperature was initially set at 50 °C for 2 min. The oven temperature was then increased to 300 °C at a rate following a total run time of 49 min:
| Steps | Rate | Final temperature |
|---|---|---|
| 1 | 5 °C/min | 250 °C |
| 2 | 10 °C/min | 300 °C |
| 3 | 0 °C/min (off) |
The GC‒MS results of the bioactive compounds detected through comparison of the retention times of standards. The mass spectra obtained were matched with the spectra available in the National Institute Standard and Technology (NIST) database (Reference Library—NIST05a.L.). The presence of the bioactive compounds detected in the extract of M. citrifolia fruit was expressed as a percentage based on the peak area produced in the chromatogram of the GC‒MS analysis.
Collection and acclimatization of postlarval shrimp
The P. vannamei used for this study was PL 18 (mean weight = 0.06 ± 0.02 g), which was obtained from the local shrimp hatchery, iSharp, Blue Archipelago, and Terengganu branches. Before the beginning of the experiment, the samples were first acclimatized for 2 weeks in fiberglass tanks with seawater at a temperature of 28 °C and salinity of 30 ppt. The PLs were fed twice daily (at 8:00 am and 8:00 pm) during the acclimatization period with a formulated diet (brand: gold coin, 903S) containing 40% protein, 3% fiber, and 7% fat. Thereafter, the average weight and length of the shrimp at the start of the experiment were recorded as approximately 0.0816 g ± 0.01 and 22.45 mm ± 0.4, respectively.
Feeding trial of shrimp supplemented with fruit extract.
An experimental feeding trial of P. vannamei PL was conducted using the protocol previously adopted by Moh et al.48. In brief, the PLs were randomly divided into six separate treatment tanks according to the concentration of supplemented M. citrifolia fruit extract. M. citrifolia fruit extract was supplemented with commercial shrimp feed at 0, 10, 20, 30, 40, and 50 mg/g, represented as T0, T1, T2, T3, T4 and T5, respectively. The choice of the six experimental doses was based on the findings of the range finding test previously performed before the current experiment. The shrimp that received 0 mg/g PL were used as the control group. The extract was weighed according to the concentration for each supplementation and was dissolved in sterile distilled water before it was mixed evenly with the pellets. The pellets that had been supplemented with the extract were oven-dried at 40 °C like it was reiterated earlier, and the diet preparation was performed in three batches. Each batch was kept for a maximum of 10 days in a chiller (at 4 °C) to ensure freshness and to prevent the degradation of the phytochemicals mixed with the feed. The analysis of each feeding group was performed in triplicate. Each tank (dimensions: 3.300 m × 1.150 m × 0.750 m) was filled with approximately 1200 L of treated seawater and 300 shrimp. P. vannamei PLs were fed a supplemented diet four times daily at regular time intervals (0800 h, 1200 h, 1600 h, and 2000 h). The feeding trial lasted for 30 days, during which the DO concentration (5.4 mg/L ± 0.041), water temperature (28 °C ± 0.023), and salinity (30 ppt ± 0.042) were maintained at their optimum levels through continuous aeration and 20% water change at 2-day intervals.
Experimental infection with V. parahaemolyticus
After the 30-day feeding period, P. vannamei PLs were subjected to a challenge test using the bacterium V. parahaemolyticus through water immersion50. To this end, 15 shrimps weighing between 1.2 and 1.7 g from each treatment and replicate tank were transferred to a representative 1 L of treated seawater in a clear aquarium (dimensions: 18 cm × 11 cm × 9.5 cm). The challenge was performed in triplicate for each treatment tank. The AHPND strain causing V. parahaemolyticus was obtained from the Institute of Marine Biotechnology (IMB), Universiti Malaysia Terengganu. The PLs were challenged with the bacterium at a concentration of 2.678 × 106 cfu/ml (LC50) for 24 h51. The survival of the infected PLs was monitored for 24 h, during which the dead and unresponsive shrimp were collected at 4, 8, 10, 16, and 24 h.
Physiological responses of P. vannamei PL before and after the challenge test
The hepatopancreases of the P. vannamei PLs in all groups (5 shrimps each) were sampled from the cephalothorax for physiological analysis before and 24 h post inoculation with the V. parahaemolyticus used for the challenge test. The physiological aspects examined included digestive enzyme activities, antioxidant enzyme activities, and histopathology analysis of the tissue structure as well as the hepatopancreatic cells.
Digestive enzyme activity assays
A bioassay kit from BioVision was used for the analyses of digestive enzyme activity. The digestive enzymes selected for the analysis included amylase (K711-100), lipase (K722-100), and trypsin (K771-100). The colorimetric assays were performed following the protocol provided on the label by the manufacturer.
Antioxidant enzyme assays
The antioxidant enzyme activity of the test organisms was determined using the protocol contained in the EnzyChrom™ bioassay kit. This approach allowed the analysis of four antioxidant enzymes, namely, (i) catalase (ECAT-100), (ii) glutathione (DIGT-250), (iii) superoxide dismutase (ESOD-100), and (iv) thiobarbituric acid (DTBA-100).
Histopathological examination of the shrimp hepatopancreas
The histology procedure was performed following the procedure adopted by Manan et al.52, with modifications applied during the process. 5 shrimps each from the different treatments were collected for this analysis. The hepatopancreases were extracted and fixed in Davidson’s solution for a period of 24 h, followed by tissue processing using a tissue processor. The procedure for processing the tissue included dehydration through a series of alcohol exposures, followed by clearing in xylene solutions and, finally, impregnation in paraffin wax. The wax-embedded samples were sectioned at a thickness of 5 µm and adhered to clear glass slides. Hematoxylin and eosin (H&E) staining was performed, and the stained samples were mounted with dibutylphthalate polystyrene xylene (DPX). The permanent slides of the hepatopancreas tissues were micrographed using a Nikon Eclipse 80i microscope at magnifications of 100 × and 200 ×. The hepatopancreas tissues were observed, and changes in the hepatopancreatic cells were recorded.
Statistical analysis
A homogeneity test of the survival and physiological response data was performed before analysis. When unequal variance (P < 0.05) was obtained, ANOVA with Welch correction was performed at a confidence level of P = 0.05. This was followed by post hoc analysis for multiple comparisons between groups. Gameshowell comparison was used when Welch ANOVA was employed, whereas if Welch ANOVA was used during the analysis of variance, Tukey’s HSD test was chosen at the confidence level P = 0.05. The results obtained after analysis are presented in graphs, tables, and figures as appropriate. All the statistical analyses were performed using Minitab 14 software.
Ethical approval
All the applicable guidelines for the use and care of animals were established in accordance with international, national, and institutional standards.
Results
Gas chromatography–mass spectrometry for determination of bioactive constituents
A total of 45 active constituents were detected via GC‒MS analysis and are shown in Table 1. The retention times and chromatograms of the compounds detected during the analysis are presented in Table 2 and Fig. 1. Cyclononasiloxane and octadecamethyl—were found to be abundant in the fruit extract of M. citrifolia, covering 36.207% of the total area in the GC‒MS peak chart. 3-Amino-3-(6,7,9,10,12,13,15,16-octahydro-5,8,11,14,17-pentaoxa-benzocyclopenta-decen-2-yl)-propionic acid was the second most abundant compound and covered 7.614% of the total peak area, followed by 2-ethylacridine and n-hexadecanoic acid, which covered 4.177% and 4.038%, respectively, of the total peak area. Additional bioactive compounds detected and their abundances are listed in Table 1. 2,4-Dihydroxy-2,5-dimethyl-3(2H)-furan-3-one was detected first at a retention time of 7.91 min, followed by hexanoic acid at 8.73 min and 4H-pyran-4-one and 2,3-dihydro-3,5-dihydroxy-6-methyl- at 13.04 min. Multiple detections of the same compound at different retention times were recorded, as shown in Table 2, with some of the major compounds being octanoic acid, benzoic acid from different isomers, cyclononasiloxane, and octadecamethyl, among others.
Table 1.
Gas chromatography‒mass spectrometry (GC‒MS) analysis of the active compounds present in the fruit extract of M. citrifolia.
| No. | Chemical compound | Molecular formula | Molecular weight (g/mol) | Percentage area (%) |
|---|---|---|---|---|
| 1 | Cyclononasiloxane, octadecamethyl- | C18H54O9Si9 | 667.4 | 36.207 |
| 2 | 3-Amino-3-(6,7,9,10,12,13,15,16-octahydro-5,8,11,14,17-pentaoxa-benzocyclopenta- decen-2-yl)-propionic acid | NA | NA | 7.614 |
| 3 | 2-Ethylacridine | C15H13N | 207.27 | 4.177 |
| 4 | n-Hexadecanoic acid (Palmitic acid) | C16H32O2 | 256.42 | 4.038 |
| 5 | Stigmastan-3,5-diene | C29H48 | 396.7 | 3.673 |
| 6 | Scillirosidin, glycoside | C26H34O7 | 458.5 | 2.905 |
| 7 | 3,4-Dihydroxymandelic acid, ethyl ester, tri-TMS | C19H36O5Si3 | 428.7 | 2.751 |
| 8 | 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- | C6H8O4 | 144.12 | 2.619 |
| 9 | Adamantane-1-(3,3-dichloropropyn-1-yl) | C13H16Cl2 | 243.17 | 2.577 |
| 10 | Octasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyl- | C16H48O7Si8 | 577.2 | 2.212 |
| 11 | 1H-Indole-2-carboxylic acid, 6-(4-ethoxyphenyl)-3-methyl-4-oxo-4,5,6,7-tetrahydro-, isopropyl ester | NA | NA | 2.209 |
| 12 | [1,1′-Biphenyl]-2,5-diol | C12H10O2 | 186.211 | 2.166 |
| 13 | 3′-Chlorooxanilic acid N'-(3-ethoxy-4-hydroxybenzylidene)hydrazide | C17H16ClN3O4 | 361.8 | 2.059 |
| 14 | 2-Hydroxy-3-(4-methoxy-benzyl)-succinic acid, dimethyl ester | NA | NA | 1.964 |
| 15 | Phenanthro[3,2-b]furan-7,11-dione, 1,2,3,4,8,9-hexahydro-4,4,8-trimethyl-, (+)- | NA | NA | 1.963 |
| 16 | 1-Hexacosene | C26H52 | 364.7 | 1.893 |
| 17 | 1-cis-Styryl-4-trans-styrylbenzene | C22H18 | 282.378 | 1.412 |
| 18 | 2-(Acetoxymethyl)-3-(methoxycarbonyl)biphenylene | C17H14O4 | 282.29 | 1.383 |
| 19 | Benzoic acid, 2-[(trimethylsilyl)amino]-, trimethylsilyl ester | C13H22O3Si2 | 282.48 | 1.307 |
| 20 | Benz[e]azulene-3,8-dione, 5-[(acetyloxy)methyl]-3a,4,6a,7,9,10,10a,10b-octahydro-3a,10a-dihydroxy-2,10-dimethyl-, (3a.alpha.,6a.alpha.,10.beta.,10a.beta.,10b.beta.)-(+)- | C19H24O6 | 384.4 | 1.280 |
| 21 | 1H-Pyrido[3,4-b]indole, 2,3,4,9-tetrahydro-1-methyl- | NA | NA | 1.241 |
| 22 | Octanoic acid | C8H16O2 | 144.21 | 1.187 |
| 23 | Dihydrotachysterol | C28H46O | 398.7 | 0.881 |
| 24 | Hexanoic acid | C6H12O2 | 116.16 | 0.859 |
| 25 | Gibb-3-ene-1,10-dicarboxylic acid, 2,4a-dihydroxy-1-methyl-8-methylene-, 1,4a-lactone, 10-methyl ester, (1.alpha.,2.beta.,4a.alpha.,4b.beta.,10.beta.)- | NA | NA | 0.712 |
| 26 | 1-Naphthol, 2,5,8-trimethyl- | C13H14O | 186.25 | 0.706 |
| 27 | Bicyclo[4.1.0]hept-4-en-2,3-dicarboxylic acid, 5,6,7,7-tetramethyl-, dimethyl ester | NA | NA | 0.690 |
| 28 | 2,4-Dihydroxy-2,5-dimethyl-3(2H)-furan-3-one | C6H8O4 | 144.12 | 0.689 |
| 29 | 4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)- | NA | NA | 0.648 |
| 30 | Silicic acid, diethyl bis(trimethylsilyl) ester | C10H28O4Si3 | 296.58 | 0.593 |
| 31 | 2-Hydroxy-4-isopropylnaphthalene | C13H14O | 186.25 | 0.586 |
| 32 | Z-5-Methyl-6-tetradecen-1-ol acetate | C17H32O2 | 268.435 | 0.571 |
| 33 | 4-Dehydroxy-N-(4,5-methylenedioxy-2-nitrobenzylidene)tyramine | C16H14N2O4 | 298.29 | 0.542 |
| 34 | cis-2,3-Di-p-tolyl-1-phthalimido-azimine | NA | NA | 0.523 |
| 35 | 5-Bromo-n-pentanol, cyclohexyl ether | C11H21BrO | 249.19 | 0.483 |
| 36 | Androst-5,7,9(11)-triene, 3-acetoxy-17-oxo- | NA | NA | 0.424 |
| 37 | Benzo[h]quinoline, 2,4-dimethyl- | C15H13N | 207.27 | 0.411 |
| 38 | Butanedioic acid, 2,3-diphenyl-, dimethyl ester | C18H18O4 | 298.3 | 0.385 |
| 39 | 1H-2-Indenone,2,4,5,6,7,7a-hexahydro-3-(1-methylethyl)-7a-methyl | C13H20O | 192.3 | 0.340 |
| 40 | 1,3-Benzenedithiol | C6H6S2 | 142.2 | 0.257 |
| 41 | trans-4-Ethoxy-4′-methoxychalcone | C18H18O3 | 282.3 | 0.250 |
| 42 | 7-Chloro-2-cyclohexyl-4[3H]quinazolinone | NA | NA | 0.223 |
| 43 | 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one | NA | NA | 0.178 |
| 44 | 2,4(1H,3H)-Quinolinedione, 3-benzoyl-3-(phenylmethyl)- | C23H17NO3 | 355.4 | 0.124 |
| 45 | Benzoic acid, 2,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester | C16H30O4Si3 | 370.66 | 0.090 |
Table 2.
Retention time (in minutes) of bioactive compounds detected during GC‒MS analysis.
| Retention time (min) | Bioactive compounds |
|---|---|
| 7.91 | 2,4-Dihydroxy-2,5-dimethyl-3(2H)-furan-3-one |
| 8.73 | Hexanoic acid |
| 13.06 | 4H-Pyran-4-one,2,3-dihydro-3,5-dihydroxy-6-methyl- |
| 14.22 | Octanoic acid |
| 14.24 | Octanoic acid |
| 20.05 | 1,3-Benzenedithiol |
| 23.34 | 2,4(1H,3H)-Quinolinedione,3-benzoyl-3-(phenylmethyl)- |
| 23.37 | Benzoic acid, 2,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester |
| 27.54 | Cyclononasiloxane, octadecamethyl- |
| 27.58 | Cyclononasiloxane, octadecamethyl- |
| 27.61 | Cyclononasiloxane, octadecamethyl- |
| 27.64 | Cyclononasiloxane, octadecamethyl- |
| 27.70 | Cyclononasiloxane, octadecamethyl- |
| 27.72 | Cyclononasiloxane, octadecamethyl- |
| 29.75 | 1-Naphthol, 2,5,8-trimethyl- |
| 29.78 | 2-Hydroxy-4-isopropylnaphthalene |
| 30.64 | Cyclononasiloxane, octadecamethyl- |
| 31.27 | cis-2,3-Di-p-tolyl-1-phthalimido-azimine |
| 31.94 | 1H-Pyrido[3,4-b]indole, 2,3,4,9-tetrahydro-1-methyl- |
| 32.62 | n-Hexadecanoic acid |
| 33.16 | 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one |
| 33.18 | 1H-2-Indenone,2,4,5,6,7,7a-hexahydro-3-(1-methylethyl)-7a-methyl |
| 33.31 | 3,4-Dihydroxymandelic acid, ethyl ester, tri-TMS |
| 35.70 | Cyclononasiloxane, octadecamethyl- |
| 35.92 | 5-Bromo-n-pentanol, cyclohexyl ether |
| 36.01 | Z-5-Methyl-6-tetradecen-1-ol acetate |
| 37.91 | Cyclononasiloxane, octadecamethyl- |
| 39.98 | Cyclononasiloxane, octadecamethyl- |
| 40.87 | Benzoic acid, 2-[(trimethylsilyl)amino]-, trimethylsilyl ester |
| 41.92 | Cyclononasiloxane, octadecamethyl- |
| 43.16 | 1-Hexacosene |
| 43.44 | Bicyclo[4.1.0]hept-4-en-2,3-dicarboxylic acid, 5,6,7,7-tetramethyl-, dimethyl ester |
| 43.89 | Cyclononasiloxane, octadecamethyl- |
| 44.89 | 4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)- |
| 44.98 | 1-cis-Styryl-4-trans-styrylbenzene |
| 45.02 | trans-4-Ethoxy-4′-methoxychalcone |
| 45.06 | 2-Hydroxy-3-(4-methoxy-benzyl)-succinic acid, dimethyl ester |
| 45.42 | Cyclononasiloxane, octadecamethyl- |
| 45.53 | Butanedioic acid, 2,3-diphenyl-, dimethyl ester |
| 45.84 | 1-Hexacosene |
| 45.97 | Androst-5,7,9(11)-triene, 3-acetoxy-17-oxo- |
| 46.54 | Octasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyl- |
| 46.61 | Cyclononasiloxane, octadecamethyl- |
| 46.67 | 7-Chloro-2-cyclohexyl-4[3H]quinazolinone |
| 46.79 | 3-Amino-3-(6,7,9,10,12,13,15,16-octahydro-5,8,11,14,17-pentaoxa-benzocyclopenta- decen-2-yl)-propionic acid |
| 46.88 | Phenanthro[3,2-b]furan-7,11-dione, 1,2,3,4,8,9-hexahydro-4,4,8-trimethyl-, (+)- |
| 47.00 | [1,1′-Biphenyl]-2,5-diol |
| 47.06 | Dihydrotachysterol |
| 47.19 | 4-Dehydroxy-N-(4,5-methylenedioxy-2-nitrobenzylidene)tyramine |
| 47.28 | Octasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyl- |
| 47.34 | Adamantane-1-(3,3-dichloropropyn-1-yl) |
| 47.51 | Octasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyl- |
| 47.54 | 2-(Acetoxymethyl)-3-(methoxycarbonyl)biphenylene |
| 47.62 | Cyclononasiloxane, octadecamethyl- |
| 47.70 | 1H-Indole-2-carboxylic acid, 6-(4-ethoxyphenyl)-3-methyl-4-oxo-4,5,6,7-tetrahydro-, isopropyl ester |
| 47.77 | 3′-Chlorooxanilic acid N'-(3-ethoxy-4-hydroxybenzylidene)hydrazide |
| 47.79 | 2-Ethylacridine |
| 47.83 | Octasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyl- |
| 47.86 | Gibb-3-ene-1,10-dicarboxylic acid, 2,4a-dihydroxy-1-methyl-8-methylene-, 1,4a-lactone, 10-methyl ester, (1.alpha.,2.beta.,4a.alpha.,4b.beta.,10.beta.)- |
| 47.95 | 2-Ethylacridine |
| 48.12 | 2-Ethylacridine |
| 48.15 | 1H-Indole-2-carboxylic acid, 6-(4-ethoxyphenyl)-3-methyl-4-oxo-4,5,6,7-tetrahydro-, isopropyl ester |
| 48.27 | Adamantane-1-(3,3-dichloropropyn-1-yl) |
| 48.30 | Silicic acid, diethyl bis(trimethylsilyl) ester |
| 48.36 | 2-(Acetoxymethyl)-3-methoxycarbonyl)biphenylene |
| 48.40 | Scillirosidin, glycoside |
| 48.50 | Cyclononasiloxane, octadecamethyl- |
| 48.69 | Benz[e]azulene-3,8-dione,5-[(acetyloxy)methyl]-3a,4,6a,7,9,10,10a,10b-octahydro-3a,10a-dihydroxy-2,10-dimethyl-, (3a.alpha.,6a.alpha.,10.beta.,10a.beta.,10b.beta.)-(+)- |
| 48.83 | Benzo[h]quinoline, 2,4-dimethyl- |
| 48.89 | Stigmastan-3,5-diene |
Figure 1.
Chromatogram of the bioactive constituents detected via gas chromatography‒mass spectrometry.
Survival of the shrimp during the challenge test with V. parahaemolyticus
The results showed that supplementation with higher concentrations of M. citrifolia fruit extract increased the survival of the shrimp during V. parahaemolyticus challenge (P = 0.024), with the highest supplementation concentration of 50 mg/g resulting in significantly greater survival than that of the control. However, below this level of supplementation, the performance was similar to that of the control and the highest treatment tested, as shown in Fig. 2.
Figure 2.
Survival of P. vannamei PLs from different feeding groups after 24 h of challenge with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Digestive enzyme activities
Significant differences in digestive enzyme activities were observed for all the shrimp groups. Generally, amylase activity was greater in the higher supplementation groups (10 mg/g onward) than in the control group (P < 0.001) before and after challenge with V. parahaemolyticus (Fig. 3). The overall activity of amylase decreased by 78.9% (P < 0.001), as shown in Table 3. However, before the challenge test, the lipase activity significantly increased in the order of 10, 20, and 40 mg/g (Fig. 4). The control had similar values to those of the 30 mg/g treatment and were greater than those obtained in the 50 mg/g treatment.
Figure 3.
Amylase activity in P. vannamei PLs (i) before and (ii) after challenge with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Table 3.
Changes in digestive enzyme activity (%) in shrimp before and after challenge with V. parahaemolyticus.
| T0 | T1 | T2 | T3 | T4 | T5 | |
|---|---|---|---|---|---|---|
| Amylase | 72.19 ± 0.63c | 74.13 ± 1.41c | 69.94 ± 1.91b | 68.56 ± 2.23b | 48.69 ± 18.12a | 78.95 ± 1.11d |
| *Lipase | 401.95 ± 64.11e | 13.05 ± 72.30a | 24.09 ± 21.97b | 30.59 ± 17.56c | 51.67 ± 205.72d | 423.96 ± 44.28e |
| Trypsin | 63.70 ± 24.99c | 85.98 ± 12.62d | 48.38 ± 8.12b | 43.32 ± 36.82b | 5.89 ± 68.50a | 49.87 ± 19.74b |
The amount of digestive enzymes with aetheric substituents (*) increased.
Significant differences are indicated by the italicized letters, where identical letters indicate no significant difference between feeding groups. All the values are presented as the means ± SDs. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Figure 4.
Lipase activity in P. vannamei PLs (i) before and (ii) after challenge with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Upon challenge with V. parahaemolyticus, the lipase activity significantly increased in all the treatments, reaching 423% (Table 3), with the control having the highest values recorded (Fig. 4). The trypsin activity before the challenge test was greater in the treatment group than in the control group (Fig. 5). After challenge with V. parahaemolyticus, there was a significant reduction in the overall activity of trypsin, reaching 86.0% (P < 0.001), as shown in Table 3. The trypsin activity was similar in the lower groups (i.e., 0 and 10 mg/g) (P = 0.451) but greater in the supplementation groups (i.e., 20 mg/g onward) (P < 0.001), as shown in Fig. 5.
Figure 5.
Trypsin activity in P. vannamei PLs (i) before and (ii) after challenge with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Antioxidant enzymes
Significant differences in catalase activity (CAT) (Fig. 6), glutathione concentration (GSH) (Fig. 7), superoxide dismutase activity (SOD) (Fig. 8), and thiobarbituric acid reactive substances (TBARS) activity (Fig. 9) were detected among all the feeding groups. However, the higher supplemented groups (T3-T5) demonstrated the highest activities (CAT: P < 0.001; GSH: P < 0.001; SOD: P < 0.001; TBARS: P < 0.001), as shown before and after the challenge with V. parahaemolyticus.
Figure 6.
Catalase activity (U/L) in P. vannamei PLs (i) before and (ii) after challenge with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Figure 7.
Glutathione Conc. (μM) in P. vannamei PLs (i) before and (ii) after challenge with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Figure 8.
Superoxide dismutase activity (U/ml) in P. vannamei PLs (i) before and (ii) after the challenge test with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Figure 9.
TBARS concentration (µM MDA equivalent) in P. vannamei PLs (i) before and (ii) after challenge with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
In general, V. parahaemolyticus infection caused a significant reduction in the expression of all the antioxidant enzymes (CAT-78.8%, P < 0.001; GSH-55.0%, P < 0.001; SOD-68.3%, P < 0.001; and TBARS-50.4%, P < 0.001), as shown in Table 4.
Table 4.
Changes in antioxidant enzyme activities (reduction %) of shrimp before and after the challenge test with V. parahaemolyticus.
| T0 | T1 | T2 | T3 | T4 | T5 | |
|---|---|---|---|---|---|---|
| Catalase | 72.43 ± 0.33c | 77.41 ± 0.28ba | 75.39 ± 0.09b | 76.77 ± 0.17b | 76.06 ± 0.14b | 78.84 ± 0.20a |
| Glutathione | 49.17 ± 1.00b | 52.91 ± 1.98a | 53.94 ± 1.38a | 55.04 ± 4.85a | 50.45 ± 3.97ba | 47.11 ± 3.19c |
| SOD | 36.63 ± 4.61c | 54.17 ± 2.05b | 54.22 ± 0.32b | 65.48 ± 0.21a | 68.28 ± 1.09d | 63.95 ± 3.13a |
| TBARS | 42.88 ± 1.52c | 45.09 ± 0.49b | 49.37 ± 3.93a | 50.35 ± 1.61a | 48.29 ± 0.78a | 46.95 ± 1.02b |
Significant differences are indicated by the italic letters. Different letters indicate significant differences between feeding groups. All the values are presented as the means ± SDs. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Hepatopancreas analysis
From the analysis of hepatopancreatic cells (B, R, and E cells), higher cell numbers were found with increasing concentrations of M. citrifolia. A significant increase in these parameters was observed with increased extract supplementation before the challenge. The pattern of hepatopancreatic cells after challenge can be subdivided into two performance groups. The lower supplementation groups (0–30 mg/g) had lower cell counts than did the higher supplementation groups (40 and 50 mg/g), in which a greater number of cells (B cells: P < 0.001; R cells: P < 0.001; E cells: P < 0.001) were observed, as shown in Figs. 10, 11 and 12.
Figure 10.
Average number of B cells present per tubule in the hepatopancreas of P. vannamei PLs (i) before and (ii) after challenge with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Figure 11.
Average number of R cells present per tubule in the hepatopancreas of P. vannamei PL (i) before and (ii) after the challenge test with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Figure 12.
Average number of E cells present per tubule in the hepatopancreas of P. vannamei PLs (i) before and (ii) after challenge with V. parahaemolyticus. Bars with different letters differ significantly. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Generally, the percentages of B and R cells were significantly lower postchallenge (B cells, P = 0.002; R cells, P < 0.001) by 60.6% and 66.9%, respectively. However, compared with those observed before the challenge, the number of E cells significantly increased, and the increase was significantly different across the treatment groups (P = 0.016), as shown in Table 5.
Table 5.
Changes in the hepatopancreatic cell (in %) activities of shrimp before and after challenge with V. parahaemolyticus. Hepatopancreatic cells with aetheric discordance (*).
| T0 | T1 | T2 | T3 | T4 | T5 | |
|---|---|---|---|---|---|---|
| B cells (%) | 39.26 ± 12.71d | 56.27 ± 9.15b | 56.15 ± 12.09b | 60.59 ± 8.186a | 54.87 ± 13.80b | 50.57 ± 5.48c |
| R cells (%) | 44.73 ± 11.66c | 58.01 ± 10.80b | 60.31 ± 19.05b | 66.92 ± 5.40a | 40.78 ± 19.89c | 35.72 ± 19.06d |
| *E cells (%) | 16.39 ± 5.87c | 18.55 ± 13.87c | 22.63 ± 17.56ab | 23.53 ± 16.81ab | 25.07 ± 20.64a | 25.45 ± 21.30a |
Significant differences are indicated by the italicized letters, where identical letters indicate no significant difference between feeding groups. All the values are presented as the means ± SDs. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
The hepatopancreas tissues of P. vannamei PLs after the 24-h challenge test with V. parahaemolyticus are shown in Fig. 13. Some disintegration of the hepatopancreatic tubules and connective tissues was observed in the control (0 mg/g) and higher supplementation groups (40 and 50 mg/g). However, this histological degeneration was more severe in the former than in the latter. Hemocyte infiltration was observed in all the shrimp in all the feeding groups, especially in the 40 and 50 mg/g treatment groups. Additionally, separation of the myoepithelial layer from the epithelium was observed in the lower supplementation groups (0–30 mg/g). Notably, enlarged cells and healthy hepatopancreatic cells were observed among the severely damaged hepatopancreas tissues. Despite the structural changes in the hepatopancreas tissue of the shrimp, most of the tubular lumen still retained its distinctive star shape.
Figure 13.
Hepatopancreatic tissue of P. vannamei PLs that survived the challenge test with V. parahaemolyticus after 24 h of supplementation with different concentrations of M. citrifolia fruit extract under 200 × magnification. A slight sloughing of hepatopancreatic tubules (SH) and degeneration of connective tissue (CTD) were observed in the T0, T4, and T5 treatment groups. Slight hemocytic infiltration (HI) was observed in all groups, with more HI in the T4 and T5 treatment groups. Cell hypertrophy (CH) was observed in the T4 and T5 treatment groups. B cells, R cells, and E cells in the hepatopancreatic tubules appeared to be unaffected. Separation between the myoepithelial layer and the epithelium (MES) was observed in the T0-T3 treatment groups. An abnormal lumen shape (ALU) was noticeable in the T4 and T5 feeding groups. T0, T1, T2, T3, T4, and T5 represent 0, 10, 20, 30, 40, and 50 mg/g, respectively.
Discussion
Disease outbreaks are the primary constraint on aquaculture expansion and productivity; hence, identifying environmentally friendly control procedures is critical for aquaculture development51. This study revealed 45 bioactive compounds detected in the methanol extract of M. citrifolia fruit, some of which have been previously reported to have medicinal properties, such as antioxidant, anticancer, and anti-inflammatory effects48,51. Similarly, increasing survival of the shrimp PL during V. parahaemolyticus challenge was observed with increasing concentrations of the plant fruit extract. This finding indicated that the improvement in the resistance of P. vannamei PL against V. parahaemolyticus was dose dependent. This finding is supported by the results of previous studies describing the potential of plant extracts as immunostimulators in shrimp. Improved survival has been demonstrated in several aquaculture species treated with Indian herbs53, brown seaweed, Phaeophyceae polysaccharide extract54, or green tea extract55 and challenged with disease-causing pathogens. Plant extracts are known to contain active compounds whose activities have been linked to enhancing innate immune responses in aquaculture species56. Previously, M. citrifolia was reported to contain high levels of phenolics and flavonoids, as well as polysaccharides and glycoproteins48. These compounds, which are known for their antioxidant properties29, could explain the improved survival of M. citrifolia fruit extract-fortified P. vannamei PLs challenged with V. parahaemolyticus.
Digestive system enzymes are important in immunological studies because they can impact the ability of an organism to create a barrier against pathogenic infection57. Zokaeifar et al.58 reported that improved digestive enzyme activities are often associated with improved colonization of gut bacteria and, consequently, improved efficiency of pathogen elimination by the body. The evaluation of the shrimp in this study demonstrated that amylase activity increased with increasing concentrations of the plant fruit extract. Therefore, a strong correlation between the survival of the shrimp and amylase activity was observed, indicating that a higher concentration of the plant fruit extract increased the survival of the shrimp. Trypsin is another well-known immune response trigger in all organisms59. These findings align with the results of Li et al.60, who reported improved immunity with increasing trypsin activity. The authors also explained the role of trypsin in producing hemocyanin peptide in P. vannamei in response to pathogen infection during a challenge test with V. parahaemolyticus and Staphylococcus aureus60.
The shrimp hepatopancreas is recognized as an important metabolic center for physiological balance, including enzyme production for both digestion and the immune response61,62. Lipase, which is stored in the hepatopancreas of shrimp, plays an important role in lipid breakdown63. The lower lipase activities in the shrimp with increasing concentrations of supplementation in the diet could be indicative of decreased energy needs following treatment with the extract64. This is justified by the fact that lipase activities significantly increased after the 24-h challenge test, a condition that would have triggered energy dispersion for osmoregulation and defense against the infection. In line with this hypothesis, in a study by Schleder et al., lipase was reported to play a significant role in improving shrimp immune responses by increasing the utilization of lipids to improve the resistance of P. vannamei PL to V. parahaemolyticus infection65. In contrast, amylase and trypsin activities were reduced following the challenge test. The response of amylase to stress was previously reported to be relatively sensitive, which makes it a bioindicator of stress in the environment66.
The shrimps also demonstrated greater antioxidant enzyme activities with increasing concentrations of the supplement. However, all the antioxidant enzymes exhibited a reduction in activity after the challenge test. The levels of antioxidant enzymes, especially SOD and CAT, are generally reduced in shrimp after pathogen infection67,68. GSH in M. rosenbergii reportedly decreased after it was challenged with V. anguillariumm69. This reduction in antioxidant activity suggested that antioxidant enzymes were utilized during the stress conditions. A reduction in SOD activity was also reported in P. vannamei during stressful handling conditions according to the report of Mercier et al.70. Compared to those in the control group in this study, the antioxidant activities in the supplementation groups were greater. Perhaps this means that the antioxidant responses of the shrimps were slower in the control group than in the treatment group68. The slow response may have been one of the reasons for the lower survival in the control group. Therefore, M. citrifolia fruit extract may enhance the immune response of P. vannamei PL against V. parahaemolyticus through the manipulation of antioxidant enzyme activities. CAT and GSH activities often overlap during oxidative stress, where GSH functions only as a cofactor during H2O2 removal71. This explains the lower reduction in GSH compared to that in CAT in this study.
The analysis of the hepatopancreas cells of P. vannamei PLs is another important index of immunity. R cells play an important role in nutrient absorption and storage as well as the excretion and detoxification of foreign substances72. R cells are also involved in lipid accumulation for healthier growth and stress prevention in shrimp73,74. Therefore, it is no surprise that the current study revealed an increase in the R cell number with the supplementation of the fruit extract. This approach may help to significantly reduce the impact of stressful shrimp exposure to V. parahaemolyticus infection, in line with the findings of Bhavan and Geraldine75. Boudet et al.72 also explained that cells lack apocrine secretion ability, thus making them the most vulnerable cells during stress exposure. This means that stressful circumstances cause R cells to continuously store contaminants until the cell dies from toxin poisoning72,75,76. This explains the significant reduction in the number of R cells after challenge with the pathogen from V. parahaemolyticus.
Since B cells play an important role in intracellular digestion and nutrient absorption, they are believed to encounter a similar fate as R cells, causing the cells to die from toxin accumulation. The loss of B and R cells is often augmented by mitotic cell division and the activity of E cells at the distal end of tubules72. This explains the increase in the number of E-cells after infection with V. parahaemolyticus, as observed in the present study. Therefore, the balance of cell death caused by infection, viz. a viz. cell regeneration may determine whether shrimp survive or die. Moreover, since B cells are known to be derived from F cells77, infection may also damage F cells, hence affecting their conversion into B cells and reducing their availability. E cells, on the other hand, are actively dividing embryonic cells involved in cell renewal in the tubular epithelium78, hence explaining their increase despite pathogenic infection.
Although gills are known to constitute the initial line of defense for the immunity of crustaceans against pathogens and other oxidative stresses79, the hepatopancreas plays an important physiological role in system optimization75. The function of the hepatopancreas is analogous to that of the liver in higher organisms, and the hepatopancreas is sensitive and often prone to injuries caused by infection or other stress exposure75. The histopathology results in this study agree with previous studies on hepatopancreatic histological degeneration following pathogenic infection79–82. The destruction of the hepatopancreas structure often affects its function in terms of digestion, nutrient absorption, and secretion, hence leading to the deterioration of shrimp health and ultimately mortality72,79. The appearance of enlarged cells in the infected hepatopancreas is also worth mentioning. Several explanations have been articulated in the past regarding the enlargement of hepatopancreatic cells. One such complication is infection-induced enlargement of the cell because of fluid retention within its walls. This eventually breaks due to the excessive pressure build-up within, thereby giving rise to disintegrated hepatopancreas tubules83. Similarly, Bhavan and Geraldine75 reported that hypertrophies can be caused by thickening of the basal laminae of the tubules of the infected hepatopancreas. According to Nadella et al.81, such occurrences are good indications of the early defense of cells in reaction to the presence of a pathogen.
Invertebrates do not have specific, adaptive immune responses as vertebrates do; therefore, their immune responses depend exclusively on the innate, nonspecific immune system84. Hemocyte infiltration is fairly common in the infected hepatopancreas72, as hemocytes play a role in the immune responses of animals to pathogenic invasion79,81 and other toxicants72,76. These processes include phagocytosis, nodulation, and encapsulation85. The infiltration of hemocytes in the tubule is likely due to hematopoiesis (i.e., the process of hemocyte production and maturation). These hemocytes are subsequently released into the circulation system to replace damaged or damaged cells for stable cellular function86. Microorganism infections were reported to potentially reduce hemocyte counts in crustaceans, but the system was restored once the infection had stopped87. Hence, the rapid recovery of hemocytes is important for the rapid eradication of pathogens88. Therefore, the ability of crustaceans to produce hemocytes at an optimum rate is important for ensuring survival under stressful conditions. The appearance of healthy hepatopancreatic cells among the severely damaged hepatopancreas tissues is in line with the findings of the study by Sreeram and Menon89. According to Boudet et al.72, the hepatopancreas can recover and restore its structure during and after stress conditions. Therefore, the results of this study suggested that supplementation of P. vannamei PL with the methanolic extract of M. citrifolia fruit potentially improved the defense and self-recovery of the hepatopancreas following challenge with V. parahaemolyticus.
Conclusion
This study showed that M. citrifolia fruit methanolic extract supplementation in P. vannamei PL nutrition effectively improved resistance against V. parahaemolyticus during the challenge test. The best dosage of M. citrifolia fruit methanolic extract supplementation found in this study was the highest dosage (50 mg/g), which gave survival of up to 26.7% more than the control. The outcome of this study revealed that the enhanced immunity of the shrimp against V. parahaemolyticus may be associated with improved hepatopancreas health resulting from extract supplementation. This was shown by improvements in the digestive and antioxidant systems, hepatopancreas cells, and histology. Future studies can therefore test the effects of M. citrifolia fruit extract on other aquaculture species and diseases in an attempt to determine the versatility of treatments. Additionally, the potential of other parts of the plant could be the focus of future research to elucidate the biocontrol ability of these plants for aquaculture diseases (Supplementary information).
Supplementary Information
Acknowledgements
This study received funding from the Ministry of Higher Education, Malaysia, under the awarded Higher Institution Centre of Excellence (HICoE) grant (Vot No. 56046). This research was conducted using the facilities provided by the AKUATROP at the University of Malaysia Terengganu. The postlarvae used in this study were provided by iSharp Hatchery, Blue Archipelago Sdn. Bhd., Telaga Putat, Setiu, Terengganu, Malaysia. Hence, the authors thank the management and staff of the institution for supporting the conduct of this research.
Author contributions
Julia Hwei Zhong Moh: Conceptualization, methodology, investigation, formal analysis, writing—original draft. Victor Tosin Okomoda: Validation, writing—original draft, Review & editing. Mhd Ikhwanuddin: Conceptualization, supervision, validation, writing, review and editing. Nurshahieda Mohamad: Methodology, Investigation. Khor Waiho: Writing—Review & editing, formal analysis, validation. Shaibani Noorbaiduri: Methodology, investigation. Yeong Yik Sung: Validation, supervision, writing, review and editing. Muyassar H. Abualreesh: Validation, supervision, writing—review & editing. Hidayah Manan: Writing—review & editing, validation. Hanafiah Fazhan: Writing—review & editing, validation. Hongyu Ma: Validation.
Data availability
The data for this study will be made available upon request from the corresponding author.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Victor Tosin Okomoda, Email: okomodavictor@yahoo.com.
Mhd Ikhwanuddin, Email: ikhwanuddin@umt.edu.my.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-024-56173-4.
References
- 1.FAO . The Global Status of Seaweed Production, Trade and Utilization. Globefish Research Programme. FAO; 2018. p. 120. [Google Scholar]
- 2.Tacon AG. Trends in global aquaculture and aquafeed production: 2000–2017. Rev. Fish. Sci. Aquacult. 2020;28(1):43–56. doi: 10.1080/23308249.2019.1649634. [DOI] [Google Scholar]
- 3.Mude JN, Ravuru DB. Growth of cultured White leg shrimp Litopenaeus vannamei (Boone, 1931) of brackish water culture system in winter season with artificial diet. J. Aquacult. Res. Dev. 2015;6(2):1–10. [Google Scholar]
- 4.FAO. El Estado Mundial de la Pesca y la Acuicultura 2020. Versión Resumida. La Sostenibilidad en Acción. (FAO, 2020). ISBN 978-92-5-132756-2.
- 5.Briggs, M., Funge-Smith, S., Subasinghe, R. & Phillips, M. 2004. Introduction and movement of Penaeus vannamei and Penaeus stylorostris in Asia and the Pacific. Food and Agriculture Organization of the United Nations. http://www.fao.org/3/ad505e/ad505e00.htm#Contents. Accessed 3rd May 2020.
- 6.Ravuru DB, Mude JN. Growth of cultured white leg shrimp Litopenaeus vannamei (Boone, 1931) of brackish water culture system in summer season with artificial diet. Adv. Appl. Sci. Res. 2014;5(2):25–28. [Google Scholar]
- 7.Jannathulla R, Dayal JS, Ambasankar K, Thulasi D, Vasantha D. Carcass amino acid, fatty acid and mineral composition of Penaeus vannamei Boone, 1931 fed diets with fermented oilseed meals/cakes. Int. J. Fish. Aquat. Stud. 2018;6(6):233–240. [Google Scholar]
- 8.Thitamadee S, Prachumwat A, Srisala J, Jaroenlak P, Salachan PV, Sritunyalucksana K, Itsathitphaisarn O. Review of current disease threats for cultivated penaeid shrimp in Asia. Aquaculture. 2016;452:69–87. doi: 10.1016/j.aquaculture.2015.10.028. [DOI] [Google Scholar]
- 9.Wyban, J. Selective breeding of Penaeus vannamei: Impact on world aquaculture and lessons for future. in: BRAQCON 2019: World Brackishwater Aquaculture Conference. Journal of Coastal Research, Special Issue No. 86, 1–5 (eds Jithendran, K. P. et al.) (Coconut Creek, 2019). ISSN 0749-0208.
- 10.Ottinger M, Clauss K, Kuenzer C. Aquaculture: Relevance, distribution, impacts and spatial assessments: A review. Ocean Coast. Manag. 2016;119:244–266. doi: 10.1016/j.ocecoaman.2015.10.015. [DOI] [Google Scholar]
- 11.Tran L, Nunan L, Redman RM, Mohney LL, Pantoja CR, Fitzsimmons K, Lightner DV. Determination of the infectious nature of the agent of acute hepatopancreatic necrosis syndrome affecting penaeid shrimp. Dis. Aquat. Organ. 2013;105:45–55. doi: 10.3354/dao02621. [DOI] [PubMed] [Google Scholar]
- 12.Holt CC, Bass D, Stentiford GD, van der Giezen M. Understanding the role of the shrimp gut microbiome in health and disease. J. Inverteb. Pathol. 2020;1:107387. doi: 10.1016/j.jip.2020.107387. [DOI] [PubMed] [Google Scholar]
- 13.Peña-Navarro N, Castro-Vásquez R, Vargas-Leitón B, Dolz G. Molecular detection of acute hepatopancreatic necrosis disease (AHPND) in Penaeus vannamei shrimps in Costa Rica. Aquaculture. 2020;1:735190. doi: 10.1016/j.aquaculture.2020.735190. [DOI] [Google Scholar]
- 14.Jha RK, Babikian YH, Babikian HY, Le KV, Wisoyo D, Srisombat S, Jiaravanon B. Efficacy of natural herbal formulation against acute hepatopancreatic necrosis disease (AHPND) causing Vibrio parahaemolyticus in Penaeus vannamei. Vet. Med. Open J. 2016;2(1):1–6. doi: 10.17140/VMOJ-2-109. [DOI] [Google Scholar]
- 15.Dabu IM, Lim JJ, Arabit PMT, Orense SJAB, Tabardillo JA, Jr, Corre VL, Jr, Maningas MBB. The first record of acute hepatopancreatic necrosis disease in the Philippines. Aquacult. Res. 2017;48(3):792–799. doi: 10.1111/are.12923. [DOI] [Google Scholar]
- 16.Dang, L. T., Nguyen, H. T., Hoang, H. H., Lai, H. N. & Nguyen, H. T. Efficacy of rose myrtle rhodomyrtus tomentosa seed extract against acute hepatopancreatic necrosis disease in pacific whiteleg shrimp Penaeus vannamei. J. Aquat. Anim. Health. 31, 311–319 (2019). [DOI] [PubMed]
- 17.Muthukrishnan S, Defoirdt T, Ina-Salwany MY, Yusoff FM, Shariff M, Ismail SI, Natrah I. Vibrio parahaemolyticus and Vibrio harveyi causing acute hepatopancreatic necrosis disease (AHPND) in Penaeus vannamei (Boone, 1931) isolated from Malaysian shrimp ponds. Aquaculture. 2019;511:734227. doi: 10.1016/j.aquaculture.2019.734227. [DOI] [Google Scholar]
- 18.Sotomayor MA, Reyes JK, Restrepo L, Dominguez-Borbor C, Maldonado M, Bayot B. Efficacy assessment of commercially available natural products and antibiotics, commonly used for mitigation of pathogenic Vibrio outbreaks in Ecuadorian Penaeus (Litopenaeus) vannamei hatcheries. PLoS ONE. 2019;14(1):e0210478. doi: 10.1371/journal.pone.0210478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Chen H, Liu S, Xu XR, Diao ZH, Sun KF, Hao QW. Tissue distribution, bioaccumulation characteristics, and health risk of antibiotics in cultured fish from a typical aquaculture area. J. Hazard Mater. 2018;343:140–148. doi: 10.1016/j.jhazmat.2017.09.017. [DOI] [PubMed] [Google Scholar]
- 20.Vinay TN, Ray AK, Avunje S, Thangaraj SK, Krishnappa H, Viswanathan B, Reddy MA, Vijayan KK, Patil PK. Vibrio harveyi biofilm as immunostimulant candidate for high-health pacific white shrimp, Penaeus vannamei farming. Fish Shellfish Immunol. 2019;95:498–505. doi: 10.1016/j.fsi.2019.11.004. [DOI] [PubMed] [Google Scholar]
- 21.Tsai CY, Santos HM, Hu SY, Sang CY, Yanuaria CAS, Lola ENG, Tayo LL, Nitura KMA, Liu CH, Chuang KP. LpxD gene knockout elicits protection to Litopenaeus vannamei, white shrimp, against Vibrio parahaemolyticus infection. Aquacult. Int. 2019;27(5):1383–1393. doi: 10.1007/s10499-019-00398-y. [DOI] [Google Scholar]
- 22.Liu X, Steele JC, Meng XZ. Usage, residue, and human health risk of antibiotics in Chinese aquaculture: A review. Environ. Pollut. 2017;223:161–169. doi: 10.1016/j.envpol.2017.01.003. [DOI] [PubMed] [Google Scholar]
- 23.Dawood MAO, Koshio S, Abdel-Daim MM, Van Doan H. Probiotic application for sustainable aquaculture. Rev. Aquac. 2019;11(3):907–924. doi: 10.1111/raq.12272. [DOI] [Google Scholar]
- 24.Dawood MAO, Koshio S. Recent advances in the role of probiotics and prebiotics in carp aquaculture: A review. Aquaculture. 2016;454:243–251. doi: 10.1016/j.aquaculture.2015.12.033. [DOI] [Google Scholar]
- 25.Adel M, Yeganeh S, Dawood MAO, Safari R, Radhakrishnan S. Effects of Pediococcus pentosaceus supplementation on growth performance, intestinal microflora, and disease resistance of white shrimp, Litopenaeus vannamei. Aquacult. Nutr. 2017;23(6):1401–1409. doi: 10.1111/anu.12515. [DOI] [Google Scholar]
- 26.Situmorang ML, Suantika G, Santoso M, Khakim A, Wibowo I, Aditiawati P. Poly-β-hydroxybutyrate (PHB) improves nursery-phase pacific white shrimp Litopenaeus vannamei defense against vibriosis. N. Am. J. Aquacult. 2020;82(1):108–114. doi: 10.1002/naaq.10132. [DOI] [Google Scholar]
- 27.Manju S, Malaikozhundan B, Withyachumnarnkul B, Vaseeharan B. Essential oils of Nigella sativa protects Artemia from the pathogenic effect of Vibrio parahaemolyticus Dahv2. J. Inverteb. Pathol. 2016;136:43–49. doi: 10.1016/j.jip.2016.03.004. [DOI] [PubMed] [Google Scholar]
- 28.Peng B, Ye J, Han Y, Zeng L, Zhang J, Li H. Identification of polyvalent protective immunogens from outer membrane proteins in Vibrio parahaemolyticus to protect fish against bacterial infection. Fish Shellfish Immunol. 2016;54:204–230. doi: 10.1016/j.fsi.2016.04.012. [DOI] [PubMed] [Google Scholar]
- 29.Bulfon C, Galeotti M, Volpatti D. Medicinal plant extracts modulate respiratory burst and proliferation activity of rainbow trout (Oncorhynchus mykiss) leukocytes. Fish Physiol. Biochem. 2017;44:109–117. doi: 10.1007/s10695-017-0417-5. [DOI] [PubMed] [Google Scholar]
- 30.Kumaran T, Thanga Viji V, Velmurugan S, Citarasu T. Influence of selected antiviral herbal active principals against shrimp White Spot Syndrome virus (WSSV) Int. J. Mol. Biol. Biochem. 2014;2(1):41–49. [Google Scholar]
- 31.Maldonado-Garcia, M. et al. Antioxidant and immunostimulant potentials of Chenopodium ambrosioides Lin Pacific red snapper (Lutjanus peru). Aquaculture513, 734414. 10.1016/j.aquaculture.2019.734414 (2019).
- 32.Shabana MS, Karthika M, Ramasubramanian V. Effect of dietry Citrus sinensis peel extract on growth performance, digestive enzyme activity, muscle biochemical composition, and metabolic enzyme status of the freshwater fish, Catla catla. J. Basic Appl. Zool. 2019;80:51. doi: 10.1186/s41936-019-0119-x. [DOI] [Google Scholar]
- 33.McClatchey W. From Polynesian healer to health food stores: Changing perspectives of Morinda citrifolia (Rubiaceae) Integrat. Cancer Ther. 2002;1(2):110–120. doi: 10.1177/1534735402001002002. [DOI] [PubMed] [Google Scholar]
- 34.Nerurkar P, Hwang PW, Saksa E. Anti-diabetic potential of Noni: The Yin and the Yang. Molecules. 2015;20:17684–17719. doi: 10.3390/molecules201017684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nerurkar P, Hwang PW, Saksa E. The effect of Morinda citrifolia L. fruit juice on the blood sugar level and other serum parameters in patients with diabetes type 2. Evid. Based Complement. Altern. Med. 2015;20:3565427. doi: 10.1155/2018/3565427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kustiarini DA, Nishigaki T, Kanno H, To H. Effects of Morinda citrifolia on rheumatoid arthritis in SKG mice. Biol. Pharm. Bull. 2019;42:496–500. doi: 10.1248/bpb.b18-00480. [DOI] [PubMed] [Google Scholar]
- 37.Zhang W, Wang W, Zhang J, Wang Z, Wang Y, Hao W, Huang W. Antibacterial constituents of Hainan Morinda citrifolia (Noni) leaves. J. Food Sci. 2016;81(5):M1192–M1196. doi: 10.1111/1750-3841.13302. [DOI] [PubMed] [Google Scholar]
- 38.Sibi G, Chatly P, Adhikari S, Ravikumar KR. Phytoconstituents and their influence on antimicrobial properties of Morinda citrifolia L. Res. J. Med. Plants. 2012;6(6):441–448. doi: 10.3923/RJMP.2012.441.448. [DOI] [Google Scholar]
- 39.Halim AM, Prajitno A. Aqueous Morinda citrifolia leaves extract enhancing glutathione peroxidase activity and α2-macroglobulin gene expression and Macrobrachium rosenbergii. Res. J. Life Sci. 2017 doi: 10.21776/ub.rjls.2017.004.01.4. [DOI] [Google Scholar]
- 40.Rodríguez MGA, León JAR, Borbor CLD, Beltrán CNT, Orrala RMM. Immunomodulatory and anti-vibrio properties of plant extract to manage the health of the shrimp Penaeus vannamei. AquaTech. Rev. Iberoam. Acuicult. 2022;4(2):109–123. [Google Scholar]
- 41.Chang YH, Kuo WC, Wang HC, Chen YM. Biocontrol of acute hepatopancreatic necrosis disease (AHPND) in shrimp using a microalgal-bacterial consortium. Aquaculture. 2020;521:734990. doi: 10.1016/j.aquaculture.2020.734990. [DOI] [Google Scholar]
- 42.Lin H, Li Z, Chen Y, Zheng W, Yang K. Effect of dietary traditional Chinese medicines on apparent digestibility coefficient of nutrients for white shrimp Litopenaeus vannamei, Boone. Aquaculture. 2006;253:495–501. doi: 10.1016/j.aquaculture.2004.11.048. [DOI] [Google Scholar]
- 43.Zahran E, Risha E, AbdelHamid F, Mahgoub HA, Ibrahim T. Effects of dietary Astragalus polysaccharides (APS) on growth performance, immunological parameters, digestive enzymes, and intestinal morphology of Nile tilapia (Oreochromis niloticus) Fish Shellfish Immunol. 2014;38(1):149–157. doi: 10.1016/j.fsi.2014.03.002. [DOI] [PubMed] [Google Scholar]
- 44.Gabriel NN, Qiang J, Ma XY, Xu P, Nakwaya DN. Effects of dietary Aloe vera crude extracts on digestive enzyme activities and muscle proximate composition of GIFT tilapia juveniles. S. Afr. J. Anim. Sci. 2017;47(6):904–913. doi: 10.4314/sajas.v47i6.18. [DOI] [Google Scholar]
- 45.Li Z, Yang H, Shangguan J, Chen Q, Li W, Lu J. Growth performance, digestive enzyme activities and serum nonspecific immunity of the red tilapia (Oreochromis mossambicus × Oreochromis niloticus) fed diets supplemented with ultrafine powder of Enteromopha prolifera*. J. Oceanol. Limnol. 2018;36(5):1843–1850. doi: 10.1007/s00343-018-7142-5. [DOI] [Google Scholar]
- 46.Liu X, Xi Q, Yang L, Li H, Jiang Q, Shu G, Wang S, Gao P, Zhu X, Zhang Y. The effect of dietary Panax ginseng polysaccharide extract on the immune responses in white shrimp, Litopenaeus vannamei. Fish Shellfish Immunol. 2011;30(20):495–500. doi: 10.1016/j.fsi.2010.11.018. [DOI] [PubMed] [Google Scholar]
- 47.Wu C, Chang W, Wang J, Liu C, Wong S, Jiang C, Hsieh S. Dietary administration of Gynura bicolor (Roxb. Willd) DC water extract enhances immune response and survival rate against Vibrio alginolyticus and white spot syndrome virus in white shirmp Litopenaeus vannamei. Fish Shellfish Immunol. 2015;42(1):25–33. doi: 10.1016/j.fsi.2014.10.016. [DOI] [PubMed] [Google Scholar]
- 48.Moh JHZ, Waiho K, Fazhan H, Shaibani N, Manan H, Sung YY, Ma H, Ikhwanuddin M. Effect of Noni, Morinda citrifolia fruit extract supplementation on the growth performances and physiological responses of the hepatopancreas of Whiteleg shrimp Penaeus vannamei post larvae. Aquacult. Rep. 2021;21:100798. doi: 10.1016/j.aqrep.2021.100798. [DOI] [Google Scholar]
- 49.Natheer ES, Sekar C, Amutharaj P, Syed Abdul Rahman M, Feroz Khan K. Evaluation of antibacterial activity of Morinda citrifolia, Vitex trifolia and Chromolaena odorata. Afr. J. Pharm. Pharmacol. 2012;6(11):783–788. doi: 10.5897/AJPP11.435. [DOI] [Google Scholar]
- 50.Hong XP, Xu D, Zhuo Y, Liu HQ, Lu LQ. Identification and pathogenicity of Vibrio parahaemolyticus isolates and immune response of Penaeus (Litopenaeus) vannamei (Boone) J. Fish Dis. 2016;39(9):1085–1097. doi: 10.1111/jfd.12441. [DOI] [PubMed] [Google Scholar]
- 51.Anirudhan A, Okomoda VT, Iryani MTM, Andriani Y, Abd-Wahid ME, Tan MP, Danish-Daniel M, Wong LL, Tengku-Muhammad TS, Mok WJ, Sorgeloos P, Sung YY. Pandanus tectorius fruit extract promotes Hsp70 accumulation, immune-related gene expression and Vibrio parahaemolyticus tolerance in the white-leg shrimp Penaeus vannamei. Fish Shellfish Immunol. 2021;109:97–105. doi: 10.1016/j.fsi.2020.12.011. [DOI] [PubMed] [Google Scholar]
- 52.Manan H, Moh JHZ, Othman F, Ikhwanuddin M. Histopathology of the hepatopancreas of Pacific White Shrimp, Penaeus vannamei from none early mortality syndrome (EMS) shrimp ponds. J. Fish. Aquat. Sci. 2015;10(6):562–568. doi: 10.3923/jfas.2015.562.568. [DOI] [Google Scholar]
- 53.Citarasu T, Sivaram V, Immanuel G, Rout N, Murugan V. Influence of selected Indian immunostimulant herbs against white spot syndrome virus (WSSV) infection in black tiger shrimp, Penaeus monodon with reference to hematological, biochemical and immunological changes. Fish Shellfish Immunol. 2006;21:372–384. doi: 10.1016/j.fsi.2006.01.002. [DOI] [PubMed] [Google Scholar]
- 54.Chotigeat W, Tongsupa S, Supamataya K, Phongdara A. Effect of Fucoidan on diseases resistance of Black Tiger Shrimp. Aquaculture. 2004;233:23–30. doi: 10.1016/j.aquaculture.2003.09.025. [DOI] [Google Scholar]
- 55.Kongchum P, Chimtong S, Chareansak N, Subprasert P. Effect of green tea extract on Vibrio parahaemolyticus inhibition in pacific white shrimp (Litopenaeus vannamei) postlarvae. Agric. Agric. Sci. Procedia. 2016;11:117–124. doi: 10.1016/j.aaspro.2016.12.020. [DOI] [Google Scholar]
- 56.Chakraborty SB, Hancz C. Application of phytochemicals as immunostimulant, antipathogenic and antistress agents in finfish culture. Rev. Aquacult. 2011;3:103–119. doi: 10.1111/j.1753-5131.2011.01048.x. [DOI] [Google Scholar]
- 57.Deaton, J. Enzymes and Probiotics for Immune Health. (2018). https://www.deerland.com/chew/enzymes-and-probiotics-for-immune-health/. Accessed 20 Sept 2019.
- 58.Zokaeifar H, Balcazar JL, Saad CR, Kamarudin MS, Sijam K, Arshad A, Nejat N. Effects of Bacillus subtilis on the growth performance, digestive enzymes, immune gene expression and disease resistance of white shrimp, Litopenaeus vannamei. Fish Shellfish Immunol. 2012;33:683–689. doi: 10.1016/j.fsi.2012.05.027. [DOI] [PubMed] [Google Scholar]
- 59.Patel S. A critical review on serine protease: Key immune manipulator and pathology mediator. Allergol. Immunopathol. 2017;45(6):579–591. doi: 10.1016/j.aller.2016.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Li C, Wang F, Aweya JJ, Yao D, Zheng Z, Huang H, Li S, Zhang Y. Trypsin in Litopenaeus vannamei is required for the generation of hemocyanin-derived peptides. Dev. Comp. Immunol. 2017;79:95–104. doi: 10.1016/j.dci.2017.10.015. [DOI] [PubMed] [Google Scholar]
- 61.Xu D, Liu X, Cao J, Du Z, Huang Y, Zhao H, Zhu X, Zhou M, Lan H, Xie C. Dietary glutathione as an antioxidant improves resistance to ammonia exposure in Litopenaeus vannamei. Aquacult. Res. 2012;43(2):311–316. doi: 10.1111/j.1365-2109.2011.02820.x. [DOI] [Google Scholar]
- 62.De La Fuente M, Victor VM. Antioxidants as modulators of immune function. Immunol. Cell Biol. 2000;78(1):49–54. doi: 10.1046/j.1440-1711.2000.00884.x. [DOI] [PubMed] [Google Scholar]
- 63.Olguín-León P, Enríquez-Espinoza T, Mendoza-Cano F, Encinas-García T, Sánchez-Paz A. Transcriptional profile of pyruvate kinase and pancreatic lipase encoding mRNAs of the Pacific whiteleg shrimp Penaeus vannamei during PstDV-1 infection. Aquacult. Res. 2017 doi: 10.1111/are.13380.10.1111/ARE.13380. [DOI] [Google Scholar]
- 64.Javahery S, Noori A, Hoseinifar SH. Growth performance, immune response and digestive enzyme activity in Pacific white shrimp, Penaeus vannamei Boone, 1931, fed dietary microbial lysozyme. Fish Shellfish Immunol. 2019;92:528–535. doi: 10.1016/j.fsi.2019.06.049. [DOI] [PubMed] [Google Scholar]
- 65.Schleder DD, Peruch LGB, Poli MA, Ferreira TH, Silva CP, Andreatta ER, Hayashi L, Vieira FN. Effect of brown seaweeds on Pacific white shrimp growth performance, gut morphology, digestive enzymes activity and resistance to white spot virus. Aquaculture. 2018;495:359–365. doi: 10.1016/j.aquaculture.2018.06.020. [DOI] [Google Scholar]
- 66.Chatterton RT, Jr, Vogelsong KM, Lu Y, Ellman AB, Hudgens GA. Salivary α-amylase as a measure of endogenous adrenergic activity. Clin. Physiol. 1996;16(4):433–448. doi: 10.1111/j.1475-097X.1996.tb00731.x. [DOI] [PubMed] [Google Scholar]
- 67.Pacheco R, Ascencio F, Zarain M, Gómez G, Campa Á. Enhancement of superoxide dismutase and catalase activities in juvenile brown shrimp, Farfantepenaeus californiensis (Holmes, 1900), fed -1,3 glucan vitamin E, and β-carotene and infected with white spot syndrome virus. Latin Am. J. Aquat. Res. 2011;39(3):534–543. doi: 10.4067/S0718-560X2011000300013. [DOI] [Google Scholar]
- 68.Yeh S, Chen J. White shrimp Litopenaeus vannamei that received the hot-water extract of Gracilaria tenuistipitata showed earlier recovery in immunity after a Vibrio alginolyticus injection. Fish Shellfish Immunol. 2009;26(5):724–730. doi: 10.1016/j.fsi.2009.02.025. [DOI] [PubMed] [Google Scholar]
- 69.Kaleo IV, Gao Q, Liu B, Sun C, Zhou Q, Zhang H, Shan F, Xiong Z, Bo L, Song C. Effects of Moringa oleifera leaf extract on growth performance, physiological an immune response, and related immune gene expression of Macrobrachium rosenbergii with V. anguillarium and ammonia stress. Fish Shellfish Immunol. 2019;89:603–613. doi: 10.1016/j.fsi.2019.03.039. [DOI] [PubMed] [Google Scholar]
- 70.Mercier L, Palacios E, Campa-Córdova ÁI, Tovar-Ramírez D, Hernández-Herrera R, Racotta IS. Metabolic and immune responses in Pacific whiteleg shrimp Litopenaeus vannamei exposed to a repeated handling stress. Aquaculture. 2006;258(1–4):633–640. doi: 10.1016/j.aquaculture.2006.04.036. [DOI] [Google Scholar]
- 71.Vergauwen B, Pauwels F, van Beeumen JJ. Glutathione and catalase provide overlapping defense for protection against respiration-generated hydrogen peroxide in Haemophilus influenzae. J. Bacteriol. 2003;185(18):5555–5562. doi: 10.1128/JB.185.18.5555-5562.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Boudet LNC, Polizzi P, Romero MB, Robles A, Marcovecchio JE, Gerpe MS. Histopathological and biochemical evidence of hepatopancreatic toxicity caused by cadmium in white shrimp, Palaemonetes argentines. Ecotoxicol. Environ. Saf. 2015;113:231–240. doi: 10.1016/j.ecoenv.2014.11.019. [DOI] [PubMed] [Google Scholar]
- 73.Chen K, Li E, Xu C, Wang X, Lin H, Qin JG, Chen L. Evaluation of different lipid sources in diet of pacific white shrimp Litopenaeus vannamei at low salinity. Aquacult. Rep. 2015;2:163–168. doi: 10.1016/j.aqrep.2015.10.003. [DOI] [Google Scholar]
- 74.Johnston DJ, Calvert KA, Crear BJ, Carter CG. Dietary carbohydrate/lipid ratios and nutritional condition in juvenile southern rock lobster, Jasus edwardsii. Aquaculture. 2003;220(1–4):667–682. doi: 10.1016/S0044-8486(02)00562-8. [DOI] [Google Scholar]
- 75.Bhavan PS, Geraldine P. Histopathology of the hepatopancreas and gills of the prawn Macrobrachium malcolmsonii exposed to endosulfan. Aquat. Toxicol. 2000;50(4):331–339. doi: 10.1016/S0166-445X(00)00096-5. [DOI] [PubMed] [Google Scholar]
- 76.Wu J, Chen H, Huang D. Histopathological and biochemical evidence of hepatopancreatic toxicity caused by cadmium and zinc in the white shrimp, Litopenaeus vannamei. Chemosphere. 2008;73:1019–1026. doi: 10.1016/j.chemosphere.2008.08.019. [DOI] [PubMed] [Google Scholar]
- 77.Ribeiro K, Papa LP, Vicentini CA, Franceschini-Vicentini IB. The ultrastructural evaluation of digestive cells in the hepatopancreas of Amazon River prawn, Macrobrachium amazonicum. Aquacult. Res. 2016;47(4):1251–1259. doi: 10.1111/are.12582. [DOI] [Google Scholar]
- 78.Franceschini-Vicentini IB, Ribeiro K, Papa LP, Marques Junior J, Vicentini CA, Valenti PMCM. Histoarchitectural features of the hepatopancreas of the Amazon River prawn Macrobrachium amazonicum. Int. J. Morphol. 2009;27(1):121–128. doi: 10.4067/S0717-95022009000100022. [DOI] [Google Scholar]
- 79.Khimmakthong U, Sukkarun P. The spread of Vibrio parahaemolyticus in tissues of the Pacific white shrimp Litopenaeus vannamei analyzed by PCR and histopathology. Microb. Pathog. 2017;113:107–112. doi: 10.1016/j.micpath.2017.10.028. [DOI] [PubMed] [Google Scholar]
- 80.Velazquez-Lizarraga AE, Juarez-Moreles JL, Racotta IS, Villarreal-Colmenares H, Valdes-Lopez O, Luna-Gonzalez A, Rodriguez-Jaramillo C, Estrada N, Ascencio F. Transcriptomic analysis of Pacific White shrimp (Litopenaeus vannamei, Boone 1931) in response to acute hepatopancreatic necrosis disease caused by Vibrio parahaemolyticus. PLoS ONE. 2019;14(8):e0220993. doi: 10.1371/journal.pone.0220993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Nadella RK, Prakash RR, Dash G, Ramanathan SK, Kuttanappilly LV, Mothadaka P. Histopathological changes in giant freshwater prawn Macrobrachium rosenbergii (de Man 1879) fed with probiotic Bacillus licheniformis upon challenge with Vibrio alginolyticus. Aquacult. Res. 2017;49:81–92. doi: 10.1111/are.13436. [DOI] [Google Scholar]
- 82.Jiravanichpaisal P, Miyazaki T, Limsuwan C. Histopathology, biochemistry and pathogenicity of Vibrio harveyi infecting black tiger prawn Penaeus monodon. J. Aquat. Anim. Health. 1994;6(1):27–35. doi: 10.1577/1548-8667(1994)006<0027:HBAPOV>2.3.CO;2. [DOI] [Google Scholar]
- 83.Saptiani G, Prayitno SB, Anggoro S, Pebrianto CA. The influence of Acanthus ilicifolius extracts to histopathological on hepatopancreas of tiger shrimp (Penaeus monodon F.) Int. J. Mar. Aquat. Resourc. Convserv. Coexist. 2017;2(1):1–6. [Google Scholar]
- 84.Pope EC, Powell A, Roberts EC, Shields RJ, Wardle R, Rowley AF. Enhanced cellular immunity in shrimp (Litopenaeus vannamei) after ‘vaccination’. PLoS ONE. 2011;6(6):e20960. doi: 10.1371/journal.pone.0020960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Jiravanichpaisal P, Lee BL, Soderhall K. Cell-mediated immunity in arthropods: Hematopoiesis, coagulation, melanization and opsonization. Immunobiology. 2006;211(4):213–236. doi: 10.1016/j.imbio.2005.10.015. [DOI] [PubMed] [Google Scholar]
- 86.Barreda DR, Belosevic M. Transcriptional regulation of hemopoiesis. Dev. Comp. Immunol. 2001;25(8–9):763–789. doi: 10.1016/S0145-305X(01)00035-0. [DOI] [PubMed] [Google Scholar]
- 87.Jiravanichpaisal P, Bangyeekhun E, Soderhall K, Soderhall I. Experimental infection of white spot syndrome virus in freshwater crayfish Pacifastacus leniusculus. Dis. Aquat. Organ. 2001;47:151–157. doi: 10.3354/dao047151. [DOI] [PubMed] [Google Scholar]
- 88.Soderhall I, Bangyeekhun E, Mayo S, Soderhall K. Hemocyte production and maturation in an invertebrate animal; proliferation and gene expression in hematopoietic stem cells of Pacifastacus leniusculus. Dev. Comp. Immunol. 2003;27(8):661–672. doi: 10.1016/S0145-305X(03)00039-9. [DOI] [PubMed] [Google Scholar]
- 89.Sreeram MP, Menon NR. Histopathological changes in the hepatopancreas of the penaeid shrimp Metapenaeus dobsoni exposed to petroleum hydrocarbons. J. Mar. Biol. Assoc. India. 2005;47(2):160–168. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data for this study will be made available upon request from the corresponding author.













